Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-03-31FDA Approved: ENTYVIO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Entyvio (vedolizumab) submitted by Takeda Pharmaceuticals America, resulting in updated appr…
-
FDA approval · 2020-03-19FDA Approved: MESALAMINE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original generic application for mesalamine.
-
CLINICAL_TRIALS trial_result · 2020-03-05Clinical Trial Update: Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis [Phase 2]
Phase 2 trial of Kyowa Kirin's monoclonal antibody KHK4083 for moderate ulcerative colitis completed; results posted March 5, 2020.
-
CLINICAL_TRIALS research · 2020-03-04Clinical Trial Update: Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease [Phase 4]
A postmarketing phase 4 trial evaluating vedolizumab in lactating women with active ulcerative colitis or Crohn's disease to assess milk exp…
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease
A completed post-marketing study evaluating CT-P13 (infliximab) for standard of care treatment in inflammatory bowel diseases, including ulc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-02-12FDA Approved: MESALAMINE — Original Application (Northstar Rx LLC.)
FDA approved an original application for mesalamine (generic) submitted by Northstar Rx LLC.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis [Phase 2]
Phase 2 long-term safety trial of etrolizumab in moderate to severe ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-30Clinical Trial Update: The Colitis Once Daily Asacol Study [Phase 3]
Phase 3 clinical trial update for Colitis Once Daily Asacol study (NCT00708656) in ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2) [Phase 3]
Phase 3 trial comparing LT-02 (phosphatidylcholine) to placebo and mesalamine for maintenance of remission in ulcerative colitis has complet…
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis [Phase 3]
Phase 3 trial update on vedolizumab subcutaneous maintenance therapy for ulcerative colitis reports efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis [Phase 3]
Phase 3 trial assessing safety and efficacy of MMX Mesalamine/Mesalazine in pediatric patients with mild to moderate ulcerative colitis has …
-
CLINICAL_TRIALS withdrawal · 2020-01-18Clinical Trial Update: Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD [Phase 4]
A phase 4 clinical trial investigating escalating adalimumab for prevention of relapse in inflammatory bowel disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative Colitis [Phase 3]
Phase 3 trial update for HMPL-004 maintenance treatment in mild to moderate ulcerative colitis; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Mercaptopurine Therapy in Ulcerative Colitis [Phase 3]
Phase 3 trial update on mercaptopurine therapy for ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis [Phase 3]
A Phase III trial of HMPL-004 in mild to moderate active ulcerative colitis was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
A Phase 3 study evaluating ustekinumab induction and maintenance therapy for moderately to severely active ulcerative colitis has completed …
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean Participants
A completed clinical trial evaluating vedolizumab intravenous therapy for ulcerative colitis in Korean participants, with results posted in …
-
FDA approval · 2019-12-12FDA Approved: XELJANZ XR — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XELJANZ XR (tofacitinib) from Pfizer Laboratories Div Pfizer Inc, indicating an update to the pr…
-
FDA approval · 2019-12-06FDA Approved: AVSOLA — Original Application (Amgen, Inc)
FDA approved AVSOLA (infliximab-axxq) from Amgen as a biosimilar to infliximab, for the same indications as the reference product.
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis [Phase 3]
Phase 3 clinical trial updating mesalamine pellet formulation to maintain remission in mild to moderate ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis [Phase 3]
Phase 3 trial update for mesalamine pellet to maintain remission in mild to moderate ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity [NA]
A completed clinical trial investigated whether eliminating carrageenan from the diet affects disease activity in ulcerative colitis, with r…
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis [Phase 3]
Phase 3 trial comparing balsalazide disodium to mesalamine in mildly to moderately active ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis [Phase 3]
Phase 3 trial update describing a new tablet formulation and dosing regimen of balsalazide disodium in patients with mildly to moderately ac…
-
FDA approval · 2019-11-20FDA Approved: MESALAMINE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original application for MESALAMINE by Mylan Pharmaceuticals Inc. for a generic mesalamine product. The listing identifies …